SCI-induced deficits in antiviral immunity: The role of sTNF.
SCI 引起的抗病毒免疫缺陷:sTNF 的作用。
基本信息
- 批准号:10441446
- 负责人:
- 金额:$ 49.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-30 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibodiesAntigen PresentationAntiviral ResponseApoptosisAttenuatedBiologicalCD8-Positive T-LymphocytesCause of DeathCellsChestChronicComplexDataDendritic CellsEnvironmental Risk FactorEquilibriumGlutamatesGoalsHyperactivityImmuneImmune System DiseasesImmune responseImmune systemImmunityImpairmentIndividualInfectionInflammationInflammatoryInfluenza A virusInjuryInterneuronsLeadLifeLongevityLungMediatingMediator of activation proteinModelingMusNF-kappa BNeuronal PlasticityNeuronsOutcomePathologicPatientsPeripheralPersonsPharmacologyPlayPneumoniaPopulationReflex actionRegulationRiskRoleSignal TransductionSpinalSpinal CordSpinal cord injurySpinal cord injury patientsSplenocyteT cell responseTNF geneTNFRSF1A geneTestingThoracic spinal cord structureViral Load resultVirus Diseasesantiviral immunitybasecell typeexperimental studygenetic approachhealthspanhospital readmissionhypothalamic-pituitary-adrenal axisimmune depressionimprovedinfluenzavirusinsightlymphoid organmacrophagemortalitynervous system disorderneuroinflammationneuronal excitabilityneutrophilpatch clamppathogenpreventreceptorrecruittherapy development
项目摘要
Abstract
Individuals suffering from chronic neurological disorders, such as spinal cord injury (SCI), are at greater
risk of serious life-threatening complications from infections, including Influenza A virus (IAV) and pneumonia.
Infections are the leading cause of re-hospitalization and mortality in patients living with chronic SCI.
Therefore, reducing complications from infections is critical for improving the health and life span of SCI
patients.
Several groups, including ours, have endeavored to uncover the mechanisms underlying SCI-induced
immune depression. For example, high-thoracic (T3) SCI disrupts sympathetic regulation of lymphoid organs
and leads to impaired antibody synthesis and increased splenocyte apoptosis. Elegant studies by Ueno and
colleagues demonstrated that high-thoracic SCI-induced immune dysfunction is due, in large part, to massive
reorganization of the spinal sympathetic reflex circuit, e.g. the recruitment of glutamatergic interneurons, that
results in increased sensitivity of this circuit. Silencing these glutamatergic interneurons restored immune
balance, in the absence of pathogen challenge, demonstrating that immune balance can be affected by
neurogenic mechanisms. However, the mediator(s) of pathological plasticity and glutamatergic interneuron
activation post-SCI have not been established. We have exciting preliminary data suggesting that inhibiting
soluble Tumor Necrosis Factor (sTNF) in the spinal cord following SCI: attenuates neuroinflammation and
aberrant neuronal plasticity and activation, reduces immune dysfunction, and improves antiviral immunity
(reduced viral load, increased specific CD8 T cells).
Collectively, these data provide for a strong scientific premise to explore the role of sTNF in SCI-
induced immune dysfunction. We hypothesize that heightened levels of sTNF in the spinal cord after
injury play a crucial role in triggering robust neuroinflammation (e.g., NF-kB activation) and aberrant
plasticity that, in turn, lead to hyperactivity of sympathetic circuitry after SCI and peripheral immune
dysfunction.
These important findings highlight the role of local sTNF signaling in influencing peripheral immunity.
Based upon these data, in the following specific aims, we will:
Aim 1: Determine the extent that sTNF/TNFR1 signaling in neurons contributes to immune
depression following SCI.
Aim 2: Investigate the contribution of sTNF to extrinsic (peripheral) factors of impaired antiviral immune
responses in chronic SCI mice.
摘要
患有慢性神经系统疾病的个体,如脊髓损伤(SCI),
感染(包括甲型流感病毒(IAV)和肺炎)导致严重危及生命的并发症的风险。
感染是慢性SCI患者再次住院和死亡的主要原因。
因此,减少感染并发症对改善SCI患者的健康和寿命至关重要
患者
包括我们在内的几个研究小组都致力于揭示SCI诱导的细胞凋亡的潜在机制。
免疫抑制例如,高位胸(T3)SCI破坏了淋巴器官的交感神经调节
并导致抗体合成受损和脾细胞凋亡增加。上野的优雅研究,
他的同事证明,高胸SCI诱导的免疫功能障碍在很大程度上是由于大量的
脊髓交感神经反射回路的重组,例如脊髓交感神经能中间神经元的募集,
导致该电路的灵敏度增加。沉默这些神经元能恢复免疫
平衡,在没有病原体挑战的情况下,表明免疫平衡可能受到以下因素的影响:
神经机制然而,病理性可塑性介质和神经递质能中间神经元
SCI后激活尚未建立。我们有令人兴奋的初步数据表明,
SCI后脊髓中的可溶性肿瘤坏死因子(sTNF):减轻神经炎症,
异常的神经元可塑性和激活,减少免疫功能障碍,提高抗病毒免疫力
(病毒载量减少,特异性CD 8 T细胞增加)。
总的来说,这些数据为探索sTNF在SCI中的作用提供了强有力的科学前提。
诱发免疫功能紊乱。我们推测,脊髓中sTNF水平的升高可能与脊髓损伤有关。
损伤在触发强烈的神经炎症中起关键作用(例如,NF-kB激活)和异常
可塑性,这反过来又导致SCI后交感神经回路的过度活跃和外周免疫
功能障碍
这些重要的发现强调了局部sTNF信号在影响外周免疫中的作用。
根据这些数据,我们将在以下具体目标中:
目的1:确定神经元中sTNF/TNFR 1信号通路对免疫应答的贡献程度。
SCI后抑郁症
目的2:探讨sTNF在抗病毒免疫受损的外在(外周)因素中的作用
慢性SCI小鼠的反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Roland Bethea其他文献
John Roland Bethea的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Roland Bethea', 18)}}的其他基金
SCI-induced deficits in antiviral immunity: The role of sTNF.
SCI 引起的抗病毒免疫缺陷:sTNF 的作用。
- 批准号:
10207806 - 财政年份:2019
- 资助金额:
$ 49.2万 - 项目类别:
SCI-induced deficits in antiviral immunity: The role of sTNF.
SCI 引起的抗病毒免疫缺陷:sTNF 的作用。
- 批准号:
10019418 - 财政年份:2019
- 资助金额:
$ 49.2万 - 项目类别:
SCI-induced deficits in antiviral immunity: The role of sTNF.
SCI 引起的抗病毒免疫缺陷:sTNF 的作用。
- 批准号:
10657427 - 财政年份:2019
- 资助金额:
$ 49.2万 - 项目类别:
Soluble TNFa in the development of autonomic dysreflexia after spinal cord injury
可溶性 TNFa 在脊髓损伤后自主神经反射异常发展中的作用
- 批准号:
10386794 - 财政年份:2018
- 资助金额:
$ 49.2万 - 项目类别:
Soluble TNFa in the development of autonomic dysreflexia after spinal cord injury
可溶性 TNFa 在脊髓损伤后自主神经反射异常发展中的作用
- 批准号:
9902562 - 财政年份:2018
- 资助金额:
$ 49.2万 - 项目类别:
Enhancing supraspinal plasticity to improve functional recovery after SCI
增强脊髓上可塑性以改善 SCI 后的功能恢复
- 批准号:
9976601 - 财政年份:2017
- 资助金额:
$ 49.2万 - 项目类别:
Enhancing supraspinal plasticity to improve functional recovery after SCI
增强脊髓上可塑性以改善 SCI 后的功能恢复
- 批准号:
9193741 - 财政年份:2016
- 资助金额:
$ 49.2万 - 项目类别:
Astrocytes Play a Critical Role in the Pathology of EAE
星形胶质细胞在 EAE 病理学中发挥关键作用
- 批准号:
8824782 - 财政年份:2009
- 资助金额:
$ 49.2万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 49.2万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 49.2万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 49.2万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 49.2万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 49.2万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 49.2万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 49.2万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 49.2万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 49.2万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 49.2万 - 项目类别: